Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

Do Not Leave Batch Records in Uncontrolled Office Areas

Posted on May 25, 2025 By digi

Do Not Leave Batch Records in Uncontrolled Office Areas

Keep Batch Records Secure—Never Leave Them in Uncontrolled Offices

Remember: GMP documentation such as BMRs must be stored in secure, access-controlled locations—not left unattended in uncontrolled environments.

Why This Matters in GMP

Batch Manufacturing Records (BMRs) are critical GMP documents containing traceable evidence of every stage in drug production. Leaving them in open-access office areas exposes them to unauthorized s, damage, misplacement, or tampering. Uncontrolled handling compromises data integrity, traceability, and audit readiness. GMP requires tight control over documents, especially those impacting batch release. Proper storage safeguards against loss, falsification, or unintentional changes. Once production is complete, BMRs must be transferred to secure QA archives where only trained and authorized personnel can access them.

Also Read:  How GMP Ensures Product Quality Throughout the Pharmaceutical Supply Chain

Regulatory and Compliance Implications

FDA 21 CFR Part 211.180 and 211.186 mandate secure storage and controlled access to GMP documentation. EU GMP Chapter 4 emphasizes the protection of data from unauthorized access or alteration. WHO GMP and Schedule M require documented systems for record control and archival. During audits, inspectors look for evidence of document protection, including locked storage, SOP compliance, and access restrictions. Leaving BMRs in uncontrolled areas may lead to data integrity observations and questions on quality system robustness.

Implementation Best Practices

  • Designate secure, access-controlled rooms for BMR review and archival.
  • Transfer BMRs to QA-controlled areas immediately after line clearance or batch completion.
  • Implement logs for tracking movement and access to GMP records.
  • Use locked filing cabinets or digital systems with access rights for document control.
  • Train all staff to report misplaced or unattended documents as quality incidents.
Also Read:  Conduct Routine Gown Integrity Checks in GMP Cleanrooms

Regulatory References

  • FDA 21 CFR Part 211.180 – General Requirements
  • FDA 21 CFR Part 211.186 – Master Production and Control Records
  • EU GMP Chapter 4 – Documentation
  • WHO GMP – Documentation Storage and Protection
  • Schedule M – GMP Record Keeping and Access Control
GMP Tips Tags:batch record storage, BMR control, data protection, document control system, documentation audit, documentation integrity, EU GMP Chapter 4, FDA 21 CFR Part 211, GMP compliance, record traceability, Schedule M, uncontrolled access, WHO GMP

Post navigation

Previous Post: Using Inspection Metrics to Drive Continuous GMP Improvement

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog
Widget Image
  • Do Not Leave Batch Records in Uncontrolled Office Areas

    Do Not Leave Batch Records… Read more

GMP Tips

  • Do Not Leave Batch Records in Uncontrolled Office Areas
  • Implement UV Sterilization Protocols in GMP Change Rooms
  • Do Not Allow Incomplete Documentation During GMP Batch Record Review
  • Assign Identification Numbers to All Cleaning Tools for Traceability
  • Never Use Damaged Sieves or Mesh During Granulation in GMP
  • Conduct Alarm Challenge Tests to Validate Critical GMP System Responses
  • Do Not Ignore Elevated Noise Levels in GMP Classified Areas
  • Cross-Verify Certificate of Analysis (COA) With Raw Data for GMP Assurance
  • Do Not Store Chemicals Without Material Safety Data Sheets (MSDS)
  • Perform Visual Inspection of Vials Using Qualified Lighting Conditions

More about GMP Tips :

  • Conduct Routine Gown Integrity Checks in GMP Cleanrooms
  • Prohibit Forklift Use in Primary Packaging Areas to Prevent Contamination
  • Use Material Transfer Notes (MTNs) When Moving Raw Materials
  • Do Not Include Unrelated Documents in GMP Production Records
  • Monitor Utility Systems Like Water and Compressed Air for GMP Quality
  • Calibrate Laboratory Balances Regularly Using Certified Weights
  • Conduct Risk Assessments Before Implementing Process Changes
  • Do Not Store Chemicals Without Material Safety Data Sheets (MSDS)
  • Assign Identification Numbers to All Cleaning Tools for Traceability
  • Never Mix Product Labels from Different Batches in the Packaging Area
  • Label In-Process Samples with Date and Initials for Traceability
  • Review Equipment Logbooks for Completeness During GMP Audits
  • Do Not Store Clean and Dirty Garments Together in GMP Facilities
  • Never Touch Sterile Surfaces Without Wearing Gloves
  • Requalify HVAC Systems on Schedule to Maintain Environmental Control

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme